HOME > ARCHIVE
ARCHIVE
- New Nursing Care Fees to Promote Self-support, Home Care
February 3, 2003
- JMA Demands Korosho Not Raise Copayment to 30%
February 3, 2003
- Teijin to Integrate Medical, Pharma Business with Kyorin
February 3, 2003
- Nat'l Univ. Hospitals Submit Petition on Fiscal Management
February 3, 2003
- WORLD NEWS IN BRIEF
February 3, 2003
- Chugai to Start Worldwide PIII Trials of MRA for RA
February 3, 2003
- Taiho Licenses IPD-1151T to Yamanouchi in Urology
February 3, 2003
- Use of Thalidomide at Physician's Discretion, Patient's Wishes Risky
February 3, 2003
- Chugai Increases Tamiflu Production to Doses for 4,460,000 Patients
February 3, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
February 3, 2003
- Prof. Tanigawa Stresses Need to Discover ADRs through PMS
February 3, 2003
- Sankyo to Market Kureha's Mycelium-derived Health Foods
February 3, 2003
- BUSINESS NEWS IN BRIEF
February 3, 2003
- Tsuruha: Sales Up 21.8%, Ordinary Profits Up 14%
February 3, 2003
- WEBSITE NEWS
February 3, 2003
- OCT NEWS IN BRIEF
February 3, 2003
- CORPORATE ROUNDUP NEWS IN BRIEF
January 27, 2003
- Olympus: Hybrid-type Bronchoscope EVIS LUCERA BF-260 Series
January 27, 2003
- PFSB to Prepare GL on Tracking of Bio-derived Products
January 27, 2003
- Nipro Markets Thrombus Vacuum Aspiration Catheters
January 27, 2003
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
